2021 U.S.-Booked Air Volume: $4.5 million
Consolidated Global TMC: BCD

U.S.-booked air volume at pharmaceutical giant AstraZeneca fell to $4.5 million in 2021, down from $21 million in 2020 and $53 million in 2019, according to BTN estimates. Global revenue headed firmly in the opposite direction from $27 billion in 2020 to $37 billion in 2021. Emissions caused by business travel globally decreased from 314,000 metric tons in 2019 to 76,000 in 2020 and again to 72,000 in 2021, according to AstraZeneca’s 2021 sustainability report. The report also stated that “50 percent of our suppliers by spend covering upstream transportation and distribution and business travel will have science-based targets by 2025.” In July 2021, AstraZeneca closed the acquisition of Alexion Pharmaceuticals that had been announced in December 2020. The company also bought rare disease drugmaker Caelum in December 2021 and signed an agreement to acquire TeneoTwo in July 2022. Employee numbers at AstraZeneca rose from 76,100 in 2020 to 83,100 in 2021.